NuPathe Pharma

http://www.nupathe.com/
Tags:BrandHealthMedicalMedTechPharmacyProductSpecialtyWellness
A specialty pharmaceutical company commercializing ZECUITY® sumatriptan iontophoretic transdermal system (patch) for the acute treatment of migraine. In February 2014, NuPathe was acquired by Teva Pharmaceutical Industries.

Investors 1

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
26.09.2012-$28M-Migraine p...

Mentions in press and media 10

DateTitleDescriptionCategoryAuthorSource
17.01.2013NuPathe ge...The approval for the Zecuity c...--medcitynew...
09.10.2012Migraine p...Anido replaced Jane Hollingswo...--medcitynew...
26.09.2012Migraine p...Armando Anido, the CEO of the ...--medcitynew...
26.07.2012Migraine p...“My number one priority is c...--medcitynew...
25.07.2012Biopharmac...Incoming CEO and board member ...--medcitynew...
16.07.2012Migraine p...Jane Hollingsworth, NuPathe’...--medcitynew...
19.12.2011NuPathe CE...Six years after NuPathe’s la...--medcitynew...
29.11.2011NB Therape...Iontophoresis involves using e...--medcitynew...
15.11.2011NuPathe to...Migraine headaches affect abou...--medcitynew...
21.02.2011New Pittsb...Promoted Telemedicine’s pot...--medcitynew...